GENVIP – Publications

Publications

Since 2007 GENVIP has published more than 430 publications

SAFETY AND IMMUNOGENICITY OF PNEUMOCOCCAL CONJUGATE VACCINES IN PRETERM INFANTS

Carolina López-Sanguos, Irene Rivero Calle, Carmen Rodriguez Tenreiro, Peter Francis Raguindin and Federico Martinón-Torres

Pubmed Full article

Doi:

Expert Opin Drug Saf

Factor de impacto:

Q2

Doi:

¿QUÉ HEMOS APRENDIDO SOBRE ROTAVIRUS EN ESPAÑA EN LOS ÚLTIMOS 10 AÑOS?

Javier Díez-Domingo, María Garcés-Sánchez, Francisco Giménez-Sánchez, Javier Colomina-Rodríguez, Federico Martinón-Torres

Pubmed Full article

Doi:

An Pediatr (Barc)

Factor de impacto:

Q3

Doi:

LIFESTYLE AND COMORBID CONDITIONS AS RISK FACTORS FOR COMMUNITY-ACQUIRED PNEUMONIA IN OUTPATIENT ADULTS (NEUMO-ES-RISK project)

Irene Rivero-Calle, Miriam Cebey-López, Jacobo Pardo-Seco, José Yuste, Esther Redondo, Diego A Vargas, Enrique Mascarós,Jose Luis Díaz-Maroto, Manuel Linares-Rufo, Isabel Jimeno, Angel Gil, Jesus Molina, Daniel Ocaña,Federico Martinón-Torres, on behalf of NEUMOEXPERTOS group

Pubmed Full article

Doi:

BMJ Open Respir Res

Factor de impacto:

Doi:

EFFICACY, IMMUNOGENICITY, AND SAFETY OF A QUADRIVALENT INACTIVATED INFLUENZA VACCINE IN CHILDREN AGED 6–35 MONTHS: A MULTI-SEASON RANDOMISED PLACEBO-CONTROLLED TRIAL IN THE NORTHERN AND SOUTHERN HEMISPHERES

Stephanie Pepin, Martin Dupuy, Charissa Fay Corazon Borja-Tabora, May Montellanoc, Lulu Bravo, Jaime Santos, Jo-Anne de Castro, Doris Maribel Rivera-Medina, Clare Cutland, Miguel Ariza, Javier Diez-Domingo, Celia Diaz Gonzalez, Federico Martinón-Torres, Efimia Papadopoulou-Alataki, Maria Theodoriadou, Marie Pierre Kazek-Duret, Sanjay Gurunathan, Iris De Bruijn, for the GQM05 Study Group

Pubmed Full article

Doi:

Vaccine

Factor de impacto:

Q2

Doi:

ROTAVIRUS INFECTION BEYOND THE GUT

José Gómez-Rial, Sonia Sánchez-Batán, Irene Rivero-Calle, Jacobo Pardo-Seco, José María Martinón-Martínez, Antonio Salas, Federico Martinón-Torres

Pubmed Full article

Doi:

Infection and Drug Resistance

Factor de impacto:

Q2

Doi:

IMPLEMENTING UNIVERSAL VARICELLA VACCINATION IN EUROPE: THE PATH FORWARD

Vana Spoulou, Sophie Alain, Giovanni Gabutti, Carlo Giaquinto, Johannes Liese, Federico Martinon-Torres and Timo Vesikari

Pubmed Full article

Doi:

Pediatric Infect Dis J

Factor de impacto:

Q2

Doi:

Descripción de la gripe B en las epidemias estacionales de España

Raúl Ortiz de Lejarazu, Javier Diez Domingo, Ángel Gil de Miguel, Federico Martinón-Torres, Carlos Guzmán Quilo, José María Guillén, Blanca Piedrafita, Esther Redondo Marguello

Pubmed Full article

Doi:

Rev, Esp. Quimioterapia

Factor de impacto:

Q4

Doi:

EVALUATION OF A HEXAVALENT-PENTAVALENT-HEXAVALENT INFANT PRIMARY VACCINATION SERIESFOLLOWED BY A PENTAVALENT BOOSTER VACCINE IN HEALTHY INFANTS AND TODDLERS

Federico Martinόn-Torres, Javier Diez-Domingo, Emmanuel Feroldi, Emilia Jordanov, Siham B’Chir, and Xavier Da Costa, Hospital Clinico Universitario de Santiago de Compostela, Spain;FISABIO-Public Health,Valencia, Spain; Sanofi Pasteur, France; Sanofi Pasteur, USA

Pubmed Full article

Doi:

Pediatric Infect Dis J

Factor de impacto:

Q2

Doi:

ANAMNESTIC IMMUNE RESPONSE AND SAFETY OF AN INACTIVATED QUADRIVALENT INFLUENZA VACCINE IN PRIMED VERSUS VACCINE-NAÏVE CHILDREN

Claeys C, Chandrasekaran V, García-Sicilia J, Prymula R, Díez-Domingo J, Brzostek J, Marès-Bermúdez J, Martinón-Torres, Pollard AJ, Růžková R, Martinez AC, Ulied A, Valdivieso MM, Faust SN, Snape MD, Friel D, Ollinger T, Soni J, Schuind A, Li P, Innis BL, Jain VK.

Pubmed Full article

Doi:

Pediatric Infect Dis J

Factor de impacto:

Q2

Doi:

ADULT COMMUNITY ACQUIRED PNEUMONIA VACCINATION: 2018 UPDATE OF THE POSITIONING OF THE PNEUMONIA PREVENTION EXPERT GROUP

Redondo E, Rivero-Calle I, Vargas DA, Mascarós E, Díaz-Maroto JL, Linares M, Gil A, Molina J, Jimeno I, Ocaña D, Yuste JE, Martinón-Torres F, en nombre de Neumoexpertos en Prevención

Pubmed Full article

Doi:

Semergen

Factor de impacto:

Doi:

PHYLOGEOGRAPHY OF SARS-COV-2 PANDEMIC IN SPAIN: A STORY OF MULTIPLE INTRODUCTIONS, MICRO-GEOGRAPHIC STRATIFICATION, FOUNDER EFFECTS, AND SUPER-SPREADERS

Gómez-Carballa A, Bello X, Pardo-Seco J, Del Molino MLP, Martinón-Torres F, Salas A.

Zoological Research

Factor de impacto:

Q1

Doi:

Pubmed Full article

EXTRAORDINARY CLAIMS REQUIRE EXTRAORDINARY EVIDENCE IN ASSERTED MTDNA BIPARENTAL INHERITANCE

Antonio Salas, Sebastian Schönherr, Hans-Jürgen Bandelt, Alberto Gómez-Carballa, Hansi Weissensteiner (Federico Martinón Torres)

Forensic Sci Int Genet

Factor de impacto:

Q1

Doi:

Pubmed Full article

ROTAVIRUS AND AUTOIMMUNITY

Gómez-Rial J, Rivero-Calle I, Salas A, Martinón-Torres F

J Infect

Factor de impacto:

Q1

Doi:

Pubmed Full article

GLOBAL MOLECULAR EPIDEMIOLOGY OF RESPIRATORY SYNCYTIAL VIRUS FROM THE 2017-2018 INFORM-RSV STUDY

Tabor, David E; Fernandes, Fiona; Langedijk, Annefleur C; Wilkins, Deidre; Lebbink, Robert Jan; Tovchigrechko, Andrey; Ruzin, Alexey; Kragten-Tabatabaie, Leyla; Jin, Hong; Esser, Mark T; Bont, Louis J; Abram, Michael E (Martinón-Torres, Federico)

J. Clin. Microbiol

Factor de impacto:

Q1

Doi:

Pubmed Full article

QUANTITATIVE MULTIPLEX PROFILING OF THE COMPLEMENT SYSTEM TO DIAGNOSE COMPLEMENT‐MEDIATED DISEASES

Esther Willems Laura Lorés‐Motta Andrea Zanichelli Chiara Suffritti Michiel van der Flier Renate G van der Molen Jeroen D Langereis Joris van Drongelen Lambert P van den Heuvel Elena Volokhina Nicole CAJ van de Kar Jenneke Keizer‐Garritsen Michael Levin Jethro A Herberg Federico Martinon‐Torres Hans JTC Wessels Anita de Breuk Sascha Fauser Carel B Hoyng Anneke I den Hollander Ronald de Groot Alain J van Gool Jolein Gloerich Marien I de Jonge

Clinical & Translational Immunology

Factor de impacto:

Q2

Doi:

Pubmed Full article

DEVELOPMENT AND VALIDATION OF A PREDICTION MODEL FOR INVASIVE BACTERIAL INFECTIONS IN FEBRILE CHILDREN AT EUROPEAN EMERGENCY DEPARTMENTS: MOFICHE, A PROSPECTIVE OBSERVATIONAL STUDY

Nienke N Hagedoorn, Dorine Borensztajn, Ruud Gerard Nijman, Daan Nieboer, Jethro Adam Herberg, Anda Balode, Ulrich von Both, Enitan Carrol, Irini Eleftheriou, Marieke Emonts, Michiel van der Flier, Ronald de Groot, Benno Kohlmaier, Emma Lim, Ian Maconochie, Federico Martinón-Torres, Marko Pokorn, Franc Strle, Maria Tsolia, Dace Zavadska, Werner Zenz, Michael Levin, Clementien Vermont, Henriette A Moll

Hagedoorn NN,

Factor de impacto:

Q1

Doi:

Pubmed Full article

PREVENTION OF NEW RESPIRATORY EPISODES IN CHILDREN WITH RECURRENT RESPIRATORY INFECTIONS: AN EXPERT CONSENSUS STATEMENT

Susanna Esposito, Marcus Herbert Jones, Wojciech Feleszko, José A. Ortega Martell, Oana Falup-Pecurariu, Natalia Geppe , Federico Martinón-Torres, Kun-Ling Shen, Michael Roth and Nicola Principi

Microorganisms

Factor de impacto:

Q2

Doi:

Pubmed Full article

IMMUNANTWORT AUF DIE DTPA-HBV-IPV/HIB-AUFFRISCHIMPFUNG BEI KLEINKINDERN VON MÜTTERN, DIE WÄHREND DER SCHWANGERSCHAFT MIT TDAP-IMPFSTOFF GEIMPFT WORDEN WAREN: FOLGESTUDIE EINER RANDOMISIERTEN, PLACEBOKONTROLLIERTEN STUDIE

F Martinón-Torres, SA Halperin, T Nolan, B tapiero, KP Perrett, IS de la Cueva, J García-Sicilia, Z Stranak, Vanderkooi floor, P Kosina, M Virta, JM Merino Arribas, M Miranda-Valdivieso, B Arias Novas, J Bozensky, MJ Cilleruelo Ortega, JT Ramos Amador, M Baca, Palomino E Escribano, GV Zuccotti, J Janota, PG Marchisio, L Kostanyan, N Meyer, MA Ceregido, B Cheuvart, SO Kuriyakose, N Mesaros;

Geburtshilfe Frauenheilkd

Factor de impacto:

Q2

Doi:

Pubmed Full article

REPLY TO ‘‘DIAGNOSTIC CRITERIA SETS SENSITIVITY’’

Marta Vazquez-Ortiz, Laura Argiz, Adrianna Machinena, Luis Echeverria, Cristina Blasco, Ana Prieto, Sonsoles Infante, Leticia Vila, Emilio Garcia, Purificacion Gonzalez-Delgado, Sonia Vazquez-Cortes, Simona Barni, Federico Martinon-Torres

J Allergy Clin Immunol Pract

Factor de impacto:

Q1

Doi:

Pubmed Full article

INCREASED SERUM LEVELS OF SCD14 AND SCD163 INDICATE A PREPONDERANT ROLE FOR MONOCYTES IN COVID-19 IMMUNOPATHOLOGY

Jose Gomez Rial, Maria Jose Curras Tuala, Irene Rivero Calle, Alberto Gomez Carballa, Miriam Cebey Lopez, Carmen Rodriguez Tenreiro, Ana Dacosta Urbieta, Carmen Rivero Velasco, Nuria Rodriguez Nunez, Rocio Trastoy Pena, Javier Rodriguez Garcia, Antonio Salas, Federico Martinon Torres

From Immunol

Factor de impacto:

Q1

Doi:

Pubmed Full article

GENVIP is a research group dedicated to the study of infectious diseases and the development of vaccines using Omics tools.

The team is based in Santiago de Compostela, a historic World Heritage city with great cultural wealth and a long-established university tradition. The research group is part of the Health Research Institute of Santiago de Compostela [Instituto de Investigación Sanitaria de Santiago (IDIS)], an institution that brings together the strengths of the University of Santiago and the University Clinical Hospital of Santiago de Compostela.

Covid-19; parallel sequencing; NGS; exomes; whole-genome sequencing; gene expression; RNAseq; nanostring; proteomics; proteomics